Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
China NT Pharma Group Co., Ltd. (HK:1011)
:1011
Holding HK:1011?
Track your performance easily
1011 Stock Chart & Stats
Day’s Range― - ―
52-Week RangeHK$0.17 - HK$1.40
Previous CloseN/A
Volume22.00K
Average Volume (3M)75.41K
Market Cap
HK$62.07M
Enterprise ValueHK$469.36M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.98
Next Earnings
Mar 28, 2025EPS EstimateN/A
Last Dividend Ex-Date
Jul 10, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding264,089,500
10 Day Avg. Volume87,340
30 Day Avg. Volume75,412
Standard Deviation0.38
R-Squared0.00419
Alpha0.02
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
China NT Pharma Group Co., Ltd. News
PremiumCompany Announcements
China NT Pharma Updates on Loan Capitalization and Whitewash Waiver
PremiumCompany Announcements
China NT Pharma Group Announces Reduced Net Loss Amidst Business Streamlining
PremiumCompany Announcements
China NT Pharma Delays Circular on Loan Capitalization
PremiumCompany Announcements
China NT Pharma Engages in Strategic Loan Capitalization
PremiumCompany Announcements
China NT Pharma Engages in Subscription Talks with Shareholders
PremiumCompany Announcements
China NT Pharma Group Terminates Major Acquisition
PremiumCompany Announcements
China NT Pharma Explores Debt-to-Equity Conversion
PremiumCompany Announcements
China NT Pharma Halts Trading Pending Announcement1011 FAQ
What was China NT Pharma Group Co., Ltd.’s price range in the past 12 months?
China NT Pharma Group Co., Ltd. lowest stock price was HK$0.17 and its highest was HK$1.40 in the past 12 months.
What is China NT Pharma Group Co., Ltd.’s market cap?
China NT Pharma Group Co., Ltd.’s market cap is HK$62.07M.
When is China NT Pharma Group Co., Ltd.’s upcoming earnings report date?
China NT Pharma Group Co., Ltd.’s upcoming earnings report date is Mar 28, 2025 which is in 63 days.
How were China NT Pharma Group Co., Ltd.’s earnings last quarter?
China NT Pharma Group Co., Ltd. released its earnings results on Aug 30, 2024. The company reported HK$0.003 earnings per share for the quarter, beating the consensus estimate of N/A by HK$0.003.
Is China NT Pharma Group Co., Ltd. overvalued?
According to Wall Street analysts China NT Pharma Group Co., Ltd.’s price is currently Overvalued.
Does China NT Pharma Group Co., Ltd. pay dividends?
China NT Pharma Group Co., Ltd. pays a Annually dividend of HK$0.35 which represents an annual dividend yield of N/A. See more information on China NT Pharma Group Co., Ltd. dividends here
What is China NT Pharma Group Co., Ltd.’s EPS estimate?
China NT Pharma Group Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China NT Pharma Group Co., Ltd. have?
China NT Pharma Group Co., Ltd. has 264,089,500 shares outstanding.
What happened to China NT Pharma Group Co., Ltd.’s price movement after its last earnings report?
China NT Pharma Group Co., Ltd. reported an EPS of HK$0.003 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China NT Pharma Group Co., Ltd.?
Currently, no hedge funds are holding shares in HK:1011
---
China NT Pharma Group Co., Ltd. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-50.00%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-68.03%
Trailing 12-Months
Company Description
China NT Pharma Group Co., Ltd.
China NT Pharma Group Co Ltd is a technology-based pharmaceutical company. It is engaged in research and development, production, and sale of private label drugs, as well as the provision of pharmaceutical marketing and promotion services in China. Its products cover therapeutic areas such as the central nervous system (CNS), osteology, oncology, and hematology. The company operates in a single segment of Proprietary products production and sales.
---
Technical Analysis
Starlight Culture Entertainment Group Limited
―
China Modern Dairy Holdings Ltd.
―
Lion Rock Group
―
Kuaishou Technology Class B
―
---